Literature DB >> 10587420

Cystic fibrosis lung disease: the role of nitric oxide.

H Grasemann1, F Ratjen.   

Abstract

This review summarizes current knowledge about the role of nitric oxide (NO) in cystic fibrosis (CF) lung disease. NO is endogenously produced by a group of enzymes, the NO synthases (NOSs). There are three isoforms of NOS, each encoded by different genes: neuronal (nNOS), immune or inducible (iNOS), and endothelial (eNOS) nitric oxide synthase.(1) They all form NO and L-citrulline by enzymatic oxidation of L-arginine. This reaction requires a number of cosubstrates, including molecular oxygen and tetrahydrobiopterin. It is now known whether all three isoenzymes are constitutively expressed in cells of the respiratory tract and that their gene expression is inducible.(2,3) NO production by iNOS, the "high-output" NOS, is stimulated by bacterial lipopolysaccharide (LPS) as well as proinflammatory cytokines such as interleukin (IL)-1gamma, IL-2, interferon (IFN)-gamma, and tumor necrosis factor (TNF). In contrast to nNOS and eNOS, activation of iNOS does not require an increase in intracellular Ca(2+) concentration. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10587420     DOI: 10.1002/(sici)1099-0496(199912)28:6<442::aid-ppul10>3.0.co;2-4

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  7 in total

Review 1.  Bioanalytical profile of the L-arginine/nitric oxide pathway and its evaluation by capillary electrophoresis.

Authors:  Dmitri Y Boudko
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-02-15       Impact factor: 3.205

2.  Matrix metalloproteases in BAL fluid of patients with cystic fibrosis and their modulation by treatment with dornase alpha.

Authors:  F Ratjen; C-M Hartog; K Paul; J Wermelt; J Braun
Journal:  Thorax       Date:  2002-11       Impact factor: 9.139

3.  Defective innate immunity and hyperinflammation in newborn cystic fibrosis transmembrane conductance regulator-knockout ferret lungs.

Authors:  Nicholas W Keiser; Susan E Birket; Idil A Evans; Scott R Tyler; Adrianne K Crooke; Xingshen Sun; Weihong Zhou; Joseph R Nellis; Elizabeth K Stroebele; Kengyeh K Chu; Guillermo J Tearney; Mark J Stevens; J Kirk Harris; Steven M Rowe; John F Engelhardt
Journal:  Am J Respir Cell Mol Biol       Date:  2015-06       Impact factor: 6.914

4.  Stimulated nitric oxide production and arginine deficiency in children with cystic fibrosis with nutritional failure.

Authors:  Mariëlle P K J Engelen; Gulnur Com; Yvette C Luiking; Nicolaas E P Deutz
Journal:  J Pediatr       Date:  2013-02-15       Impact factor: 4.406

5.  Extended nitric oxide measurements in exhaled air of cystic fibrosis and healthy adults.

Authors:  Markus Hofer; Luzia Mueller; Thomas Rechsteiner; Christian Benden; Annette Boehler
Journal:  Lung       Date:  2009-08-08       Impact factor: 2.584

Review 6.  Disease modifying genes in cystic fibrosis: therapeutic option or one-way road?

Authors:  Rainer Büscher; Hartmut Grasemann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-10-11       Impact factor: 3.000

Review 7.  Mechanisms of the noxious inflammatory cycle in cystic fibrosis.

Authors:  Mathilde Rottner; Jean-Marie Freyssinet; M Carmen Martínez
Journal:  Respir Res       Date:  2009-03-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.